No biotech company transforms global health alone. GreenHelix actively seeks collaborative relationships with institutions that share our commitment to scientific excellence and health equity.
Collaborative research agreements with universities and research institutes for shared laboratory access, scientific expertise, and joint publication opportunities.
Engagement with national health authorities, regulatory bodies, and government research funding agencies to create enabling policy frameworks for plant-based vaccine development.
Strategic alignment with global health organizations focused on vaccine equity, public health systems strengthening, and last-mile immunization delivery.
Technology licensing, CDMO partnerships, and commercial alliances with established biotech and agricultural biotechnology companies for platform acceleration.
Whether you're a research institution, global health organization, investor, or industry player — we want to hear from you. Let's build the future of vaccine access together.